iRhythm Holdings: Pay

iRhythm Holdings paid its 5 named executives $24.8M in total in FY2025 (Dec). CEO Quentin S. Blackford was paid $11.0M of that.

Pay$100 in the stock at the end of FY20 → $75
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Quentin S. BlackfordPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Chad PattersonChief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Minang TurakhiaM.D., M.S.; Chief Medical and Scientific Officer, and EVP, Advanced Technologies
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Patrick MurphyChief Business Officer and Chief Legal Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Daniel WilsonChief Financial Officer5
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $11.2M. The CEO of iRhythm Holdings was paid $11.0M, 2% below the median.

  1. 1Insulet
  2. 2Natera
  3. 3Resmed
  4. 4iRhythm Holdings
  5. 5Inspire Medical Systems
  6. 6Globus Medical
  7. 7Penumbra
  8. 8Alphatec1Not disclosed
  9. 9AtriCure, Inc.Not disclosed
  10. 10Fulgent Genetics, Inc.Not disclosed
  11. 11Integra LifeSciencesNot disclosed
  12. 12Lantheus HoldingsNot disclosed
  13. 13LivaNova PLCNot disclosed
  14. 14Masimo CorporationNot disclosed
  15. 15Tactile Systems TechnologyNot disclosed
  16. 16Tandem Diabetes Care, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.